Bioneer Corporation (KOSDAQ:064550)
14,480
+10 (0.07%)
Sep 16, 2025, 2:38 PM KST
Bioneer Revenue
Bioneer had revenue of 88.28B KRW in the quarter ending June 30, 2025, with 12.54% growth. This brings the company's revenue in the last twelve months to 298.51B, up 1.01% year-over-year. In the year 2024, Bioneer had annual revenue of 293.98B with 11.68% growth.
Revenue (ttm)
298.51B
Revenue Growth
+1.01%
P/S Ratio
1.25
Revenue / Employee
791.80M
Employees
377
Market Cap
373.47B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 293.98B | 30.74B | 11.68% |
Dec 31, 2023 | 263.24B | 44.84B | 20.53% |
Dec 31, 2022 | 218.39B | -5.35B | -2.39% |
Dec 31, 2021 | 223.74B | 16.76B | 8.10% |
Dec 31, 2020 | 206.99B | 170.70B | 470.33% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 5,031.69B |
Celltrion | 3,748.95B |
ALTEOGEN | 158.06B |
Yuhan | 2,165.44B |
SK Biopharmaceuticals | 620.28B |
Peptron | 5.18B |
PharmaResearch | 449.81B |
ABL Bio | 94.93B |